IP Library Granted Patent US 8,591,876
Granted Patent B2
US 8,591,876 · App. 13/325,826 · Granted Nov 26, 2013

Methods of decreasing sebum production in the skin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,591,876
App. No.
13/325,826
Granted
Nov 26, 2013
Kind
B2
Abstract

Provided herein are methods of using gaseous nitric oxide and/or at least one nitric oxide source to or decrease sebum production in the skin of a subject. In some embodiments, the nitric oxide source includes small molecule and/or macromolecular NO-releasing compounds.

Claims (7)

1. A method of decreasing sebum production in skin of a subject comprising applying a pharmaceutically acceptable composition comprising a nitric oxide (NO)-releasing compound to the skin of the subject, wherein the NO-releasing compound is present in an amount sufficient to decrease sebum production and is present in the pharmaceutically acceptable composition in an amount of 0.1% to 20% w/w in the composition, wherein the NO-releasing compound consists of N-diazeniumdiolate-functionalized macromolecules.

2. The method of claim 1 , wherein the N-diazeniumdiolate-functionalized macromolecules comprise N-diazeniumdiolate co-condensed polysiloxane macromolecules.

3. The method of claim 1 , wherein the pharmaceutically acceptable composition comprises at least one other therapeutic agent.

4. The method of claim 1 , wherein the nitric oxide is applied at a concentration that is toxic to sebum production sites.

5. The method of claim 1 , wherein the nitric oxide is applied at a concentration that is not toxic to sebum production sites.

6. The method of claim 1 , wherein the nitric oxide is applied at a concentration that is preferentially toxic to sebum production sites over keratinocytes.

7. A method of decreasing sebum production in skin of a subject comprising applying to the subject a pharmaceutically acceptable composition comprising a therapeutic agent, said therapeutic agent consisting essentially of a nitric oxide (NO)-releasing compound, wherein said NO-releasing compound is present in said composition in an amount sufficient to decrease sebum production in the skin of the subject, wherein the NO-releasing compound consists of N-diazeniumdiolate-functionalized macromolecules.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2025
From: LNHC, INC.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 071481/0040 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2024
From: NOVAN, INC.
To: LNHC, INC.
Reel/Frame 066350/0942 →
SECURITY INTEREST Recorded Oct 18, 2023
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; PFENEX INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065271/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2016
From: BAUMAN, SUSANNE; STASKO, NATHAN
To: NOVAN, INC.
Reel/Frame 037773/0484 →